 | • レポートコード：B-GIR08C2062 • 出版社/出版日：GlobalInfoResearch / 2019年8月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、122ページ • 納品方法：Eメール • 産業分類：Pharma & Healthcare |
| Single User | ￥522,000 (USD3,480) | ▷ お問い合わせ |
| Corporate User | ￥1,044,000 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートは、エルビテグラビル配合薬の世界市場について調べ、まとめました。種類別セグメントは、エルビテグラビル/コビシスタット/エムトリシタビン/テノホビルアラフェンアミド併用薬、エルビテグラビル/コビシスタット/エムトリシタビン/テノホビル併用薬等、用途別セグメントは、通信産業、医療産業等に区分しました。エルビテグラビル配合薬の世界市場概観、企業動向、企業別エルビテグラビル配合薬シェア、市場規模推移、市場規模予測（2019年-2024年）、主要地域分析（北米、ヨーロッパ、アジア等）、主要国分析（日本、中国、アメリカ等）データなどの情報が含まれています。 ・エルビテグラビル配合薬の市場概観 ・エルビテグラビル配合薬の企業概要（事業概要、製品種類、販売量、価格、売上、市場シェア等） ・エルビテグラビル配合薬の企業別販売動向、市場シェア、市場集中度、競争動向 ・エルビテグラビル配合薬の世界市場規模 ・エルビテグラビル配合薬の北米市場分析（アメリカ、カナダ、メキシコ等） ・エルビテグラビル配合薬のアメリカ市場規模推移 ・エルビテグラビル配合薬のカナダ市場規模推移 ・エルビテグラビル配合薬のメキシコ市場規模推移 ・エルビテグラビル配合薬のヨーロッパ市場分析（ドイツ、イギリス、ロシア、フランス、イタリア等） ・エルビテグラビル配合薬のドイツ市場規模推移 ・エルビテグラビル配合薬のイギリス市場規模推移 ・エルビテグラビル配合薬のロシア市場規模推移 ・エルビテグラビル配合薬のアジア太平洋市場分析（日本、中国、韓国、インド、東南アジア等） ・エルビテグラビル配合薬の日本市場規模推移 ・エルビテグラビル配合薬の中国市場規模推移 ・エルビテグラビル配合薬の韓国市場規模推移 ・エルビテグラビル配合薬のインド市場規模推移 ・エルビテグラビル配合薬の東南アジア市場規模推移 ・エルビテグラビル配合薬の南米市場分析（ブラジル、アルゼンチン等） ・エルビテグラビル配合薬の中東・アフリカ市場分析（サウジアラビア、UAE、南アフリカ等） ・エルビテグラビル配合薬の種類別分析/販売量、売上、市場シェア（エルビテグラビル/コビシスタット/エムトリシタビン/テノホビルアラフェンアミド併用薬、エルビテグラビル/コビシスタット/エムトリシタビン/テノホビル併用薬） ・エルビテグラビル配合薬の用途別分析/市場規模（通信産業、医療産業） ・エルビテグラビル配合薬の市場予測2019年-2024年（地域別予測、種類別予測、用途別予測） ・エルビテグラビル配合薬の販売チャネル・代理店・貿易業者・ディーラー分析 |
Scope of the Report:
The global Elvitegravir Combination Drugs market is valued at xx million USD in 2018 and is expected to reach xx million USD by the end of 2024, growing at a CAGR of xx% between 2019 and 2024.
The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.
North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Elvitegravir Combination Drugs.
Europe also play important roles in global market, with market size of xx million USD in 2019 and will be xx million USD in 2024, with a CAGR of xx%.
This report studies the Elvitegravir Combination Drugs market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Elvitegravir Combination Drugs market by product type and applications/end industries.
Market Segment by Companies, this report covers
Gilead Sciences
Bristol-Myers Squibb
Janssen Pharmaceutica (Johnson & Johnson)
Biocon Limited
Flamingo Pharmaceuticals Limited
IPCA Laboratories
Medisist Pharma
Affine Formulations Limited
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide Combination Drug
Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Combination Drug
Market Segment by Applications, can be divided into
Hospital
Clinic
Drug Center
Other
Table of Contents
1 Elvitegravir Combination Drugs Market Overview
1.1 Product Overview and Scope of Elvitegravir Combination Drugs
1.2 Classification of Elvitegravir Combination Drugs by Types
1.2.1 Global Elvitegravir Combination Drugs Revenue Comparison by Types (2019-2024)
1.2.2 Global Elvitegravir Combination Drugs Revenue Market Share by Types in 2018
1.2.3 Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide Combination Drug
1.2.4 Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Combination Drug
1.3 Global Elvitegravir Combination Drugs Market by Application
1.3.1 Global Elvitegravir Combination Drugs Market Size and Market Share Comparison by Applications (2014-2024)
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Drug Center
1.3.5 Other
1.4 Global Elvitegravir Combination Drugs Market by Regions
1.4.1 Global Elvitegravir Combination Drugs Market Size (Million USD) Comparison by Regions (2014-2024)
1.4.1 North America (USA, Canada and Mexico) Elvitegravir Combination Drugs Status and Prospect (2014-2024)
1.4.2 Europe (Germany, France, UK, Russia and Italy) Elvitegravir Combination Drugs Status and Prospect (2014-2024)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Elvitegravir Combination Drugs Status and Prospect (2014-2024)
1.4.4 South America (Brazil, Argentina, Colombia) Elvitegravir Combination Drugs Status and Prospect (2014-2024)
1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Elvitegravir Combination Drugs Status and Prospect (2014-2024)
1.5 Global Market Size of Elvitegravir Combination Drugs (2014-2024)
2 Manufacturers Profiles
2.1 Gilead Sciences
2.1.1 Business Overview
2.1.2 Elvitegravir Combination Drugs Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Gilead Sciences Elvitegravir Combination Drugs Revenue, Gross Margin and Market Share (2017-2018)
2.2 Bristol-Myers Squibb
2.2.1 Business Overview
2.2.2 Elvitegravir Combination Drugs Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Bristol-Myers Squibb Elvitegravir Combination Drugs Revenue, Gross Margin and Market Share (2017-2018)
2.3 Janssen Pharmaceutica (Johnson & Johnson)
2.3.1 Business Overview
2.3.2 Elvitegravir Combination Drugs Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 Janssen Pharmaceutica (Johnson & Johnson) Elvitegravir Combination Drugs Revenue, Gross Margin and Market Share (2017-2018)
2.4 Biocon Limited
2.4.1 Business Overview
2.4.2 Elvitegravir Combination Drugs Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Biocon Limited Elvitegravir Combination Drugs Revenue, Gross Margin and Market Share (2017-2018)
2.5 Flamingo Pharmaceuticals Limited
2.5.1 Business Overview
2.5.2 Elvitegravir Combination Drugs Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 Flamingo Pharmaceuticals Limited Elvitegravir Combination Drugs Revenue, Gross Margin and Market Share (2017-2018)
2.6 IPCA Laboratories
2.6.1 Business Overview
2.6.2 Elvitegravir Combination Drugs Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 IPCA Laboratories Elvitegravir Combination Drugs Revenue, Gross Margin and Market Share (2017-2018)
2.7 Medisist Pharma
2.7.1 Business Overview
2.7.2 Elvitegravir Combination Drugs Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 Medisist Pharma Elvitegravir Combination Drugs Revenue, Gross Margin and Market Share (2017-2018)
2.8 Affine Formulations Limited
2.8.1 Business Overview
2.8.2 Elvitegravir Combination Drugs Type and Applications
2.8.2.1 Product A
2.8.2.2 Product B
2.8.3 Affine Formulations Limited Elvitegravir Combination Drugs Revenue, Gross Margin and Market Share (2017-2018)
3 Global Elvitegravir Combination Drugs Market Competition, by Players
3.1 Global Elvitegravir Combination Drugs Revenue and Share by Players (2014-2019)
3.2 Market Concentration Rate
3.2.1 Top 5 Elvitegravir Combination Drugs Players Market Share
3.2.2 Top 10 Elvitegravir Combination Drugs Players Market Share
3.3 Market Competition Trend
4 Global Elvitegravir Combination Drugs Market Size by Regions
4.1 Global Elvitegravir Combination Drugs Revenue and Market Share by Regions
4.2 North America Elvitegravir Combination Drugs Revenue and Growth Rate (2014-2019)
4.3 Europe Elvitegravir Combination Drugs Revenue and Growth Rate (2014-2019)
4.4 Asia-Pacific Elvitegravir Combination Drugs Revenue and Growth Rate (2014-2019)
4.5 South America Elvitegravir Combination Drugs Revenue and Growth Rate (2014-2019)
4.6 Middle East and Africa Elvitegravir Combination Drugs Revenue and Growth Rate (2014-2019)
5 North America Elvitegravir Combination Drugs Revenue by Countries
5.1 North America Elvitegravir Combination Drugs Revenue by Countries (2014-2019)
5.2 USA Elvitegravir Combination Drugs Revenue and Growth Rate (2014-2019)
5.3 Canada Elvitegravir Combination Drugs Revenue and Growth Rate (2014-2019)
5.4 Mexico Elvitegravir Combination Drugs Revenue and Growth Rate (2014-2019)
6 Europe Elvitegravir Combination Drugs Revenue by Countries
6.1 Europe Elvitegravir Combination Drugs Revenue by Countries (2014-2019)
6.2 Germany Elvitegravir Combination Drugs Revenue and Growth Rate (2014-2019)
6.3 UK Elvitegravir Combination Drugs Revenue and Growth Rate (2014-2019)
6.4 France Elvitegravir Combination Drugs Revenue and Growth Rate (2014-2019)
6.5 Russia Elvitegravir Combination Drugs Revenue and Growth Rate (2014-2019)
6.6 Italy Elvitegravir Combination Drugs Revenue and Growth Rate (2014-2019)
7 Asia-Pacific Elvitegravir Combination Drugs Revenue by Countries
7.1 Asia-Pacific Elvitegravir Combination Drugs Revenue by Countries (2014-2019)
7.2 China Elvitegravir Combination Drugs Revenue and Growth Rate (2014-2019)
7.3 Japan Elvitegravir Combination Drugs Revenue and Growth Rate (2014-2019)
7.4 Korea Elvitegravir Combination Drugs Revenue and Growth Rate (2014-2019)
7.5 India Elvitegravir Combination Drugs Revenue and Growth Rate (2014-2019)
7.6 Southeast Asia Elvitegravir Combination Drugs Revenue and Growth Rate (2014-2019)
8 South America Elvitegravir Combination Drugs Revenue by Countries
8.1 South America Elvitegravir Combination Drugs Revenue by Countries (2014-2019)
8.2 Brazil Elvitegravir Combination Drugs Revenue and Growth Rate (2014-2019)
8.3 Argentina Elvitegravir Combination Drugs Revenue and Growth Rate (2014-2019)
8.4 Colombia Elvitegravir Combination Drugs Revenue and Growth Rate (2014-2019)
9 Middle East and Africa Revenue Elvitegravir Combination Drugs by Countries
9.1 Middle East and Africa Elvitegravir Combination Drugs Revenue by Countries (2014-2019)
9.2 Saudi Arabia Elvitegravir Combination Drugs Revenue and Growth Rate (2014-2019)
9.3 UAE Elvitegravir Combination Drugs Revenue and Growth Rate (2014-2019)
9.4 Egypt Elvitegravir Combination Drugs Revenue and Growth Rate (2014-2019)
9.5 Nigeria Elvitegravir Combination Drugs Revenue and Growth Rate (2014-2019)
9.6 South Africa Elvitegravir Combination Drugs Revenue and Growth Rate (2014-2019)
10 Global Elvitegravir Combination Drugs Market Segment by Type
10.1 Global Elvitegravir Combination Drugs Revenue and Market Share by Type (2014-2019)
10.2 Global Elvitegravir Combination Drugs Market Forecast by Type (2019-2024)
10.3 Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide Combination Drug Revenue Growth Rate (2014-2024)
10.4 Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Combination Drug Revenue Growth Rate (2014-2024)
11 Global Elvitegravir Combination Drugs Market Segment by Application
11.1 Global Elvitegravir Combination Drugs Revenue Market Share by Application (2014-2019)
11.2 Elvitegravir Combination Drugs Market Forecast by Application (2019-2024)
11.3 Hospital Revenue Growth (2014-2019)
11.4 Clinic Revenue Growth (2014-2019)
11.5 Drug Center Revenue Growth (2014-2019)
11.6 Other Revenue Growth (2014-2019)
12 Global Elvitegravir Combination Drugs Market Size Forecast (2019-2024)
12.1 Global Elvitegravir Combination Drugs Market Size Forecast (2019-2024)
12.2 Global Elvitegravir Combination Drugs Market Forecast by Regions (2019-2024)
12.3 North America Elvitegravir Combination Drugs Revenue Market Forecast (2019-2024)
12.4 Europe Elvitegravir Combination Drugs Revenue Market Forecast (2019-2024)
12.5 Asia-Pacific Elvitegravir Combination Drugs Revenue Market Forecast (2019-2024)
12.6 South America Elvitegravir Combination Drugs Revenue Market Forecast (2019-2024)
12.7 Middle East and Africa Elvitegravir Combination Drugs Revenue Market Forecast (2019-2024)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
Figure Elvitegravir Combination Drugs Picture
Table Product Specifications of Elvitegravir Combination Drugs
Table Global Elvitegravir Combination Drugs and Revenue (Million USD) Market Split by Product Type
Figure Global Elvitegravir Combination Drugs Revenue Market Share by Types in 2018
Figure Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide Combination Drug Picture
Figure Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Combination Drug Picture
Table Global Elvitegravir Combination Drugs Revenue (Million USD) by Application (2014-2024)
Figure Elvitegravir Combination Drugs Revenue Market Share by Applications in 2018
Figure Hospital Picture
Figure Clinic Picture
Figure Drug Center Picture
Figure Other Picture
Table Global Market Elvitegravir Combination Drugs Revenue (Million USD) Comparison by Regions 2014-2024
Figure North America Elvitegravir Combination Drugs Revenue (Million USD) and Growth Rate (2014-2024)
Figure Europe Elvitegravir Combination Drugs Revenue (Million USD) and Growth Rate (2014-2024)
Figure Asia-Pacific Elvitegravir Combination Drugs Revenue (Million USD) and Growth Rate (2014-2024)
Figure South America Elvitegravir Combination Drugs Revenue (Million USD) and Growth Rate (2014-2024)
Figure Middle East and Africa Elvitegravir Combination Drugs Revenue (Million USD) and Growth Rate (2014-2024)
Figure Global Elvitegravir Combination Drugs Revenue (Million USD) and Growth Rate (2014-2024)
Table Gilead Sciences Basic Information, Manufacturing Base and Competitors
Table Gilead Sciences Elvitegravir Combination Drugs Type and Applications
Table Gilead Sciences Elvitegravir Combination Drugs Revenue, Gross Margin and Market Share (2017-2018)
Table Bristol-Myers Squibb Basic Information, Manufacturing Base and Competitors
Table Bristol-Myers Squibb Elvitegravir Combination Drugs Type and Applications
Table Bristol-Myers Squibb Elvitegravir Combination Drugs Revenue, Gross Margin and Market Share (2017-2018)
Table Janssen Pharmaceutica (Johnson & Johnson) Basic Information, Manufacturing Base and Competitors
Table Janssen Pharmaceutica (Johnson & Johnson) Elvitegravir Combination Drugs Type and Applications
Table Janssen Pharmaceutica (Johnson & Johnson) Elvitegravir Combination Drugs Revenue, Gross Margin and Market Share (2017-2018)
Table Biocon Limited Basic Information, Manufacturing Base and Competitors
Table Biocon Limited Elvitegravir Combination Drugs Type and Applications
Table Biocon Limited Elvitegravir Combination Drugs Revenue, Gross Margin and Market Share (2017-2018)
Table Flamingo Pharmaceuticals Limited Basic Information, Manufacturing Base and Competitors
Table Flamingo Pharmaceuticals Limited Elvitegravir Combination Drugs Type and Applications
Table Flamingo Pharmaceuticals Limited Elvitegravir Combination Drugs Revenue, Gross Margin and Market Share (2017-2018)
Table IPCA Laboratories Basic Information, Manufacturing Base and Competitors
Table IPCA Laboratories Elvitegravir Combination Drugs Type and Applications
Table IPCA Laboratories Elvitegravir Combination Drugs Revenue, Gross Margin and Market Share (2017-2018)
Table Medisist Pharma Basic Information, Manufacturing Base and Competitors
Table Medisist Pharma Elvitegravir Combination Drugs Type and Applications
Table Medisist Pharma Elvitegravir Combination Drugs Revenue, Gross Margin and Market Share (2017-2018)
Table Affine Formulations Limited Basic Information, Manufacturing Base and Competitors
Table Affine Formulations Limited Elvitegravir Combination Drugs Type and Applications
Table Affine Formulations Limited Elvitegravir Combination Drugs Revenue, Gross Margin and Market Share (2017-2018)
Table Global Elvitegravir Combination Drugs Revenue (Million USD) by Players (2014-2019)
Table Global Elvitegravir Combination Drugs Revenue Share by Players (2014-2019)
Figure Global Elvitegravir Combination Drugs Revenue Share by Players in 2017
Figure Global Elvitegravir Combination Drugs Revenue Share by Players in 2018
Figure Global Top 5 Players Elvitegravir Combination Drugs Revenue Market Share in 2018
Figure Global Top 10 Players Elvitegravir Combination Drugs Revenue Market Share in 2018
Figure Global Elvitegravir Combination Drugs Revenue (Million USD) and Growth Rate (%) (2014-2019)
Table Global Elvitegravir Combination Drugs Revenue (Million USD) by Regions (2014-2019)
Table Global Elvitegravir Combination Drugs Revenue Market Share by Regions (2014-2019)
Figure Global Elvitegravir Combination Drugs Revenue Market Share by Regions (2014-2019)
Figure Global Elvitegravir Combination Drugs Revenue Market Share by Regions in 2018
Figure North America Elvitegravir Combination Drugs Revenue and Growth Rate (2014-2019)
Figure Europe Elvitegravir Combination Drugs Revenue and Growth Rate (2014-2019)
Figure Asia-Pacific Elvitegravir Combination Drugs Revenue and Growth Rate (2014-2019)
Figure South America Elvitegravir Combination Drugs Revenue and Growth Rate (2014-2019)
Figure Middle East and Africa Elvitegravir Combination Drugs Revenue and Growth Rate (2014-2019)
Table North America Elvitegravir Combination Drugs Revenue by Countries (2014-2019)
Table North America Elvitegravir Combination Drugs Revenue Market Share by Countries (2014-2019)
Figure North America Elvitegravir Combination Drugs Revenue Market Share by Countries (2014-2019)
Figure North America Elvitegravir Combination Drugs Revenue Market Share by Countries in 2018
Figure USA Elvitegravir Combination Drugs Revenue and Growth Rate (2014-2019)
Figure Canada Elvitegravir Combination Drugs Revenue and Growth Rate (2014-2019)
Figure Mexico Elvitegravir Combination Drugs Revenue and Growth Rate (2014-2019)
Table Europe Elvitegravir Combination Drugs Revenue (Million USD) by Countries (2014-2019)
Figure Europe Elvitegravir Combination Drugs Revenue Market Share by Countries (2014-2019)
Figure Europe Elvitegravir Combination Drugs Revenue Market Share by Countries in 2018
Figure Germany Elvitegravir Combination Drugs Revenue and Growth Rate (2014-2019)
Figure UK Elvitegravir Combination Drugs Revenue and Growth Rate (2014-2019)
Figure France Elvitegravir Combination Drugs Revenue and Growth Rate (2014-2019)
Figure Russia Elvitegravir Combination Drugs Revenue and Growth Rate (2014-2019)
Figure Italy Elvitegravir Combination Drugs Revenue and Growth Rate (2014-2019)
Table Asia-Pacific Elvitegravir Combination Drugs Revenue (Million USD) by Countries (2014-2019)
Figure Asia-Pacific Elvitegravir Combination Drugs Revenue Market Share by Countries (2014-2019)
Figure Asia-Pacific Elvitegravir Combination Drugs Revenue Market Share by Countries in 2018
Figure China Elvitegravir Combination Drugs Revenue and Growth Rate (2014-2019)
Figure Japan Elvitegravir Combination Drugs Revenue and Growth Rate (2014-2019)
Figure Korea Elvitegravir Combination Drugs Revenue and Growth Rate (2014-2019)
Figure India Elvitegravir Combination Drugs Revenue and Growth Rate (2014-2019)
Figure Southeast Asia Elvitegravir Combination Drugs Revenue and Growth Rate (2014-2019)
Table South America Elvitegravir Combination Drugs Revenue by Countries (2014-2019)
Table South America Elvitegravir Combination Drugs Revenue Market Share by Countries (2014-2019)
Figure South America Elvitegravir Combination Drugs Revenue Market Share by Countries (2014-2019)
Figure South America Elvitegravir Combination Drugs Revenue Market Share by Countries in 2018
Figure Brazil Elvitegravir Combination Drugs Revenue and Growth Rate (2014-2019)
Figure Argentina Elvitegravir Combination Drugs Revenue and Growth Rate (2014-2019)
Figure Colombia Elvitegravir Combination Drugs Revenue and Growth Rate (2014-2019)
Table Middle East and Africa Elvitegravir Combination Drugs Revenue (Million USD) by Countries (2014-2019)
Table Middle East and Africa Elvitegravir Combination Drugs Revenue Market Share by Countries (2014-2019)
Figure Middle East and Africa Elvitegravir Combination Drugs Revenue Market Share by Countries (2014-2019)
Figure Middle East and Africa Elvitegravir Combination Drugs Revenue Market Share by Countries in 2018
Figure Saudi Arabia Elvitegravir Combination Drugs Revenue and Growth Rate (2014-2019)
Figure UAE Elvitegravir Combination Drugs Revenue and Growth Rate (2014-2019)
Figure Egypt Elvitegravir Combination Drugs Revenue and Growth Rate (2014-2019)
Figure Nigeria Elvitegravir Combination Drugs Revenue and Growth Rate (2014-2019)
Figure South Africa Elvitegravir Combination Drugs Revenue and Growth Rate (2014-2019)
Table Global Elvitegravir Combination Drugs Revenue (Million USD) by Type (2014-2019)
Table Global Elvitegravir Combination Drugs Revenue Share by Type (2014-2019)
Figure Global Elvitegravir Combination Drugs Revenue Share by Type (2014-2019)
Figure Global Elvitegravir Combination Drugs Revenue Share by Type in 2018
Table Global Elvitegravir Combination Drugs Revenue Forecast by Type (2019-2024)
Figure Global Elvitegravir Combination Drugs Market Share Forecast by Type (2019-2024)
Figure Global Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide Combination Drug Revenue Growth Rate (2014-2019)
Figure Global Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Combination Drug Revenue Growth Rate (2014-2019)
Table Global Elvitegravir Combination Drugs Revenue by Application (2014-2019)
Table Global Elvitegravir Combination Drugs Revenue Share by Application (2014-2019)
Figure Global Elvitegravir Combination Drugs Revenue Share by Application (2014-2019)
Figure Global Elvitegravir Combination Drugs Revenue Share by Application in 2018
Table Global Elvitegravir Combination Drugs Revenue Forecast by Application (2019-2024)
Figure Global Elvitegravir Combination Drugs Market Share Forecast by Application (2019-2024)
Figure Global Hospital Revenue Growth Rate (2014-2019)
Figure Global Clinic Revenue Growth Rate (2014-2019)
Figure Global Drug Center Revenue Growth Rate (2014-2019)
Figure Global Other Revenue Growth Rate (2014-2019)
Figure Global Elvitegravir Combination Drugs Revenue (Million USD) and Growth Rate Forecast (2019-2024)
Table Global Elvitegravir Combination Drugs Revenue (Million USD) Forecast by Regions (2019-2024)
Figure Global Elvitegravir Combination Drugs Revenue Market Share Forecast by Regions (2019-2024)
Figure North America Elvitegravir Combination Drugs Revenue Market Forecast (2019-2024)
Figure Europe Elvitegravir Combination Drugs Revenue Market Forecast (2019-2024)
Figure Asia-Pacific Elvitegravir Combination Drugs Revenue Market Forecast (2019-2024)
Figure South America Elvitegravir Combination Drugs Revenue Market Forecast (2019-2024)
Figure Middle East and Africa Elvitegravir Combination Drugs Revenue Market Forecast (2019-2024)
エルビテグラビル/コビシスタット/エムトリシタビン/テノホビルアラフェンアミド併用薬の世界市場予測 2024年：メーカー別、地域別、種類・用途別（～2024） Scope of the Report: The worldwide market for Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide Combination Drug is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2024, from xx million US$ in 2019, according to a new GIR (Global Info Resear…- テノホビルアラフェンアミド及び併用薬の世界市場予測 2024年：企業別、地域別、種類・用途別（～2024） Scope of the Report: The global Tenofovir Alafenamide and Its Combination Drugs market is valued at xx million USD in 2018 and is expected to reach xx million USD by the end of 2024, growing at a CAGR of xx% between 2019 and 2024. The Asia-Pacific will occupy for more market share in following years…
- テノホビル/エムトリシタビン配合剤の世界市場予測 2024年：メーカー別、地域別、種類・用途別（～2024） Scope of the Report: The worldwide market for Tenofovir/Emtricitabine Combination Drug is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2024, from xx million US$ in 2019, according to a new GIR (Global Info Research) study. This report focuses on th…
- エファビレンツ/テノホビル/エムトリシタビン配合薬の世界市場予測 2024年：メーカー別、地域別、種類・用途別（～2024） Scope of the Report: The worldwide market for Efavirenz/Tenofovir/Emtricitabine Combination Drug is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2024, from xx million US$ in 2019, according to a new GIR (Global Info Research) study. This report foc…
- メトプロロール配合薬の世界市場予測 2024年：企業別、地域別、種類・用途別（～2024） Scope of the Report: The global Metoprolol Combination Drugs market is valued at xx million USD in 2018 and is expected to reach xx million USD by the end of 2024, growing at a CAGR of xx% between 2019 and 2024. The Asia-Pacific will occupy for more market share in following years, especially in Chi…